Complement C3 levels are elevated in morbid obesity due to C3-resistance, which is partly mediated by vitamin D deficiency.
ID
Bron
Verkorte titel
Aandoening
Morbid obesity
Type 2 diabetes
Cardiovascular disease
Vitamin D deficiency
Morbide obesitas
Diabetes mellitus type 2
Hart- en vaatziekten
Vitamine D deficiëntie
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
To evaluate the effect of bariatric surgery induced weight loss on the relationship between C3 and vitamin D in visceral and subcutaneous adipose tissue and serum.
Achtergrond van het onderzoek
Rationale: There is increasing evidence that the immune system is closely linked to metabolic pathways regulating adipose tissue biology, thereby influencing morbid obesity and obesity-related diseases. However, the precise link between metabolism and immunology remains unknown. Both, complement C3 and vitamin D have been associated to inflammation and metabolism in obesity. Elevated C3 levels are associated with the metabolic syndrome, dyslipidemia and insulin resistance. Unpublished data from our clinic show a negative correlation between C3 and vitamin D. The aim of this study is to investigate the biology of vitamin D and C3 in serum and adipose tissue and to investigate the relation of C3 and C3-resistance with inflammation and metabolism in obese subjects.
Objective: To investigate the relationship between C3 and vitamin D in adipose tissue and serum in morbidly obese subjects and in subjects who lost weight due to bariatric surgery.
Study design: A single center cross-sectional (agreement) and longitudinal (changes due to weight loss) study.
Study population: Obese patients aged 18 or older, scheduled for bariatric surgery or lean and overweight patients aged 18 or older, scheduled for laparoscopic cholecystectomy.
Main study parameters/endpoints: Agreement in perioperative C3 and vitamin D levels in visceral and subcutaneous adipose tissue (VAT, SAT) and serum and changes in both markers after weight loss due to bariatric surgery.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: After informed consent obese subjects will visit the outpatient department to undergo the standard bariatric protocol. Approximately 30 mL of extra blood needs to be collected from each subject during the standard pre- and postoperative venipuncture and one day postoperatively. Extra venipuncture will be performed in both lean and obese subjects on the day of admission and 7 days postoperatively. During preoperative screening and standard follow-up additional echocardiography, IMT and PWV measurements will be performed. During surgery two adipose tissue samples will be collected; one subcutaneous of 3 grams and one visceral sample of 5 grams. No adverse effects are to be expected during the collection of the samples. When participating subjects need to undergo elective cholecystectomy after the bariatric intervention new adipose tissue samples will be collected. The follow-up period will be 5 years.
Doel van het onderzoek
Complement C3 levels are elevated in morbid obesity due to C3-resistance, which is partly mediated by vitamin D deficiency.
Onderzoeksopzet
3 months preoperative
1 day preoperative
1 day postoperative
1 week postoperative
3 months postoperative
1 year postoperative and than annually.
Onderzoeksproduct en/of interventie
Collection of visceral and subcutaneous adipose tissue during the bariatric procedure.
Additional blood collection tube, during standard venipuncture.
Intima media thickness measurement pre- and postoperative.
Echocardiography pre- and postoperative.
Algemeen / deelnemers
Stefanie van Mil
Kleiweg 500
Rotterdam 3045PM
The Netherlands
s.vanmil@sfvg.nl
Wetenschappers
Stefanie van Mil
Kleiweg 500
Rotterdam 3045PM
The Netherlands
s.vanmil@sfvg.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Scheduled for bariatric surgery, which means BMI > 40 kg/m2 or BMI >35 kg/m2 and obesity related comorbidity.
Ages 18 or above
Informed consent
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
Previous cholecystectomy
Acute inflammatory disease 6 weeks prior to surgery
Immune modulating therapy 6 weeks prior to surgery
Patients planned for simultaneous bariatric surgery and cholecystectomy.
Previous bariatric surgery.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL5026 |
NTR-old | NTR5172 |
CCMO | NL47891.101.14 |
OMON | NL-OMON41204 |